Resumen
J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 143 |
| Número de páginas | 1 |
| Publicación | Journal of Pharmacology and Experimental Therapeutics |
| Volumen | 369 |
| N.º | 1 |
| DOI |
|
| Estado | Published - abr 2019 |
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
Huella
Profundice en los temas de investigación de 'Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS